Habtoor Leighton Group in SR 278 million Saudi project

Habtoor Leighton Group (HLG), operating as Leighton Middle East Contracting, has been awarded a second health care contract in Saudi Arabia, worth SR 278 million ($ 74 million), at King Fahd Medical City (KFMC).
The project will see the delivery of the first Proton Therapy Center in the Gulf region, and will be delivered in 50/50 joint venture with Al Latifia Trading and Contracting.
This award follows September’s announcement of HLG being selected to deliver a SR 1.18 billion ($ 316 million) health care contract in Saudi Arabia — further strengthening HLG’s health care credentials and building on HLG’s strategy to diversify its work type and expand into the growing Saudi Arabia market.
HLG’s Managing Director Jose Antonio Lopez-Monis said the delivery of the Proton Therapy Center will provide Saudi Arabia and =Gulf States, with access to the best cancer treatment technology in the world.
“HLG is very fortunate to be working on a project that will deliver the most advanced cancer treatment technology in the region,” he said.
Ayed Awadh Alqahtani, program director for the construction and preparation of the new medical centers, said KFMC is one of the leading organizations in Saudi Arabia — aiming to build state-of-the-art excellence centers across the region.
“The Proton Therapy Center will be located in Riyadh and is part of the Ministry of Health King Fahd Medical City Prince Salmon Heart Center Expansion project. Known as the PPNNCC, the project involves the construction of new medical centers on the current KFMC campus. KFMC is also setting the trend of building tertiary facilities in the region,” said Alqahtani.
The Proton Therapy Center spans three levels, including two basement levels and a striking ground floor entrance. While linked to the main hospital building and a new Central Services Building, the Proton Therapy Center is separately contained.